Stockscreener 앱 받기
60.08
1.14%
-0.625
시간 외 거래:
60.08
0.005
+0.01%
Tempus Ai Inc 주식(TEM)의 최신 뉴스
Form 144 Tempus AI For: 6 July By Investing.com - Investing.com South Africa
TEM (NASDAQ) Rule 144 notice: 10,000 restricted shares listed, prior 13,550 sold - Stock Titan
Tempus AI (TEM) Launches Next-Gen Agentic Platform to Accelerate Oncology Research - Insider Monkey
Tempus AI (TEM) Leverages AI for Precision Medicine Advancements - Yahoo Finance
Tempus AI plans $350 million convertible notes offering - Investing.com
Cathie Wood’s ARK sells AMD stock, buys Tempus AI - Investing.com
Tempus AI (TEM) Could Be 8% Undervalued After Rare Cancer Data Collaboration - simplywall.st
Cathie Wood’s ARK sells AMD stock, buys Tempus AI and Intellia - Investing.com Nigeria
Leonteq Securities AG Buys 29,116 Shares of Tempus AI, Inc. $TEM - MarketBeat
Baer Investment Advisory LLC Invests $1 Million in Tempus AI, Inc. $TEM - MarketBeat
Tempus AI, Inc. (NASDAQ:TEM) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Tempus AI (NASDAQ:TEM) Downgraded by Wall Street Zen to "Sell" - MarketBeat
Tempus AI Stock (TEM) Opinions on Revenue Growth and Market Disconnect - Quiver Quantitative
Does Tempus AI’s (TEM) Rare Cancer Data Push Reveal a Durable Precision Oncology Moat? - Yahoo Finance
Tempus AI (NASDAQ:TEM) Stock Rating Upgraded by Freedom Capital - MarketBeat
TEM Stock Slips Overnight: CEO-Linked $9.6M Share Sale Puts A Cloud Over 'AI As Physician' Story - Stocktwits
Tempus AI(TEM.US) 10% Shareholder Sells US$9.56 Million in Common Stock - Moomoo
CEO Eric Lefkofsky entities sell 166,250 Tempus AI (TEM) shares under 10b5-1 plan - Stock Titan
TEM Initiated Coverage by Freedom Capital Markets -- Rating Set to Hold - GuruFocus
Tempus AI (TEM) Holds Steady Near Support Amid Modest PullbackDollar Neutral Pair - dars.gov.et
Does Tempus AI’s (TEM) xH Launch Quietly Redraw Its Long‑Term Data Moat Strategy? - simplywall.st
Correction: Biovica Refocuses US Commercial Strategy and Terminates Agreement with Tempus AI - Yahoo Finance
Biovica Refocuses US Commercial Strategy and Terminates Agreement with Tempus AI - Yahoo! Finance Canada
Biovica Refocuses US Commercial Strategy, Terminates Deal With Tempus AI - TradingView
Biovica refocuses US commercial strategy and terminates agreement with Tempus AI - marketscreener.com
Biovica Terminates Reference Laboratory Agreement with Tempus AI and Refocuses US Commercial Strategy - marketscreener.com
Tempus AI: Buy On Diagnostics Momentum And AI Platform Expansion (NASDAQ:TEM) - Seeking Alpha
Form 4 Tempus AI Inc For: 29 June By Investing.com - Investing.com Canada
Tempus AI CFO James Rogers sells $634,095 in TEM stock - Investing.com UK
Tempus AI CFO James Rogers sells $634,095 in TEM stock By Investing.com - Investing.com Australia
Tempus AI director Jennifer Doudna sells $147,015 in stock By Investing.com - Investing.com Nigeria
Tempus AI director Jennifer Doudna sells $147,015 in stock - Investing.com
Tempus AI (TEM) CFO sells 11,529 shares under Rule 10b5-1 plan - Stock Titan
Form 144 Tempus AI For: 29 June By Investing.com - Investing.com South Africa
$Tempus AI (TEM.US)$ whats next …. - Moomoo
Tempus AI (NASDAQ: TEM) insiders report multi-holder Class A sales - Stock Titan
Tempus AI Stock Faces a Make-or-Break Moment After Its Recent Pullback - Yahoo Finance
Tempus AI, Inc. (TEM) Stock Analysis: Growth Prospects Amidst a Complex Financial Landscape - DirectorsTalk Interviews
Tempus AI (TEM) is Amongst AI stocks Under $30 That Carry High Short Interest - Insider Monkey
Tempus AI (TEM) Expands Rare Cancer Research, Is The Stock Fully Priced? - simplywall.st
5 Worst Artificial Intelligence Stocks Under $30 According to Short Sellers - Insider Monkey
How genetic testing company Tempus AI is using data and artificial intelligence to help personalize cancer care - MSN
Tempus AI Stock (TEM) Opinions on Healthcare AI Breakthroughs - Quiver Quantitative
Tempus AI Stock Short Interest Rises to 38.44% - Quiver Quantitative
Tempus AI, Inc. $TEM Shares Sold by SG Americas Securities LLC - MarketBeat
Tempus AI stock jumps on rare cancer research partnership - Investing.com
How Genetic Testing Company Tempus AI Is Using Data and Artificial Intelligence to Help Personalize Cancer Care - SurvivorNet
Why is Tempus AI stock rallying today? - Investing.com UK
TEM (NASDAQ: TEM) insider resale: 11,529 RSU shares listed for sale - Stock Titan
Why is Tempus AI stock rallying today? By Investing.com - Investing.com Nigeria
Investors Purchase High Volume of Call Options on Tempus AI (NASDAQ:TEM) - MarketBeat
Tempus AI, Inc. Class A Actuals & Estimates (NASDAQ:TEM) - TradingView
Tempus AI partners with Angiosarcoma Awareness on rare cancer research By Investing.com - Investing.com South Africa
Tempus AI stock jumps on rare cancer research partnership By Investing.com - Investing.com Nigeria
0.37%
5.00%
자본화:
|
볼륨(24시간):